Annual Meeting May 24, 2012

Competitive Technologies, Inc.  © Statements made about our future expectations are forward- looking statements and subject to risks and uncertainties as described in our most recent Annual Report on Form 10-K/A for the year ended December 31, 2011, filed with the SEC on May 15, 2012, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward- looking statement. Safe Harbor Statement

Competitive Technologies, Inc.  ©  Funding  Medical Insurance Reimbursement  Sales Growth Topics to be Discussed

Competitive Technologies, Inc.  © Basis for Optimism - Calmare Works! Frank Sparadeo, Ph.D.  Doctorate in Clinical Psychology  Private practice since 1983  Worked in hospitals in Massachusetts and Rhode Island  Taught at universities in Massachusetts and Rhode Island  Active in Calmar Pain Relief program since June 2010  Review his study of 250 patients

Competitive Technologies, Inc.  © Board Composition Board MemberMember Since Peter Brennan June 2011 Richard D. Hornidge February 2007 Rustin Howard October 2007 Robert G. Moussa January 2012 Stan Yarbro, Ph.D. March 2012

Competitive Technologies, Inc.  © Medical Device Corporations vs. CTTC Robert Moussa, CEO - Dilon Technologies 40 Years in Medical Device Industry: Chairman, President & CEO, Dilon Technologies President, Malinkrodt International President & CEO, Malinkrodt Medical Sherwood Medical

CTTC Organization Chart Competitive Technologies, Inc.  ©

8 Funding Types  Government Loan  Two year 6% notes convertible at $1.05/share  Sale of common shares

Competitive Technologies, Inc.  © Funding  SBA Loan – One million dollars  Three Investment banking groups  Private Investors

Competitive Technologies, Inc.  © Sales Personnel - Domestic Commissioned Sales Staff  Challenges have been: Reimbursement Clinical studies Long lead time for each sale

Competitive Technologies, Inc.  © Sales Personnel - Domestic Changes Planned  Hire sales employees  Ability to control time and efforts  Evaluate quality of existing commissioned sales personnel  Increase number commissioned sales personnel

Competitive Technologies, Inc.  © International Sales DistributorCountry Able Global Healthcare Sdn BhdMalaysia Biogene Pharma LimitedBangladesh Excel Life Sciences, Inc.India FintradeGreece, Cyprus GEOMC Co. Ltd.Korea, Japan Life Episteme ItaliaItaly, Malta The Mediterranean for Technology & Trading SAL Offshore Lebanon, Turkey, Iraq, Jordan, Oman, Qatar, Bahrain, Kuwait, UAE, Yemen, Saudi Arabia, Mauritania, Morocco, Algeria, Tunisia, Libya, Egypt

Competitive Technologies, Inc.  © Insurance Reimbursement  Obtain Medicare Approval Hospital – Outpatient – 1 group Hospital – Inpatient – 10 groups Doctors/Clinics – 10 different groups  Private Carriers Bottom up – work with doctors/clinics on filing claims Top down – work with insurer’s medical directors

Competitive Technologies, Inc.  © SUMMARY We have a medical device that is needed. Over 100 million people in the U.S. alone spend over $500 billion on pain. The device works as shown by clinical trials and by Dr. Sparadeo’s research.

Competitive Technologies, Inc.  © SUMMARY We have new advisory resources on our Board of Directors. The funding process is in high gear. With funding, we can push sales and insurance reimbursement. The international sales program is in place.

Competitive Technologies, Inc.  © SUMMARY Our objectives are as follows:  Move this technology to the forefront of pain therapy  Transform CTTC into a profitable growth company.

Competitive Technologies, Inc.  © THANK YOU! Competitive Technologies, Inc.